ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SXTP 60 Degrees Pharmaceuticals Inc

0.2792
0.0002 (0.07%)
After Hours
Last Updated: 16:10:42
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
60 Degrees Pharmaceuticals Inc SXTP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0002 0.07% 0.2792 16:10:42
Open Price Low Price High Price Close Price Prev Close
0.29 0.245 0.29 0.2792 0.279
more quote information »

Recent News

Date Time Source Heading
5/20/202407:59GLOBE60 Degrees Pharmaceuticals Funds Babesia spp Testing in..
5/15/202413:45GLOBE60 Degrees Pharmaceuticals Announces First Quarter 2024..
5/08/202407:59GLOBE60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial..
5/02/202407:59GLOBE60 Degrees Pharmaceuticals Receives FDA Comments on..
4/03/202407:58GLOBE60 Degrees Pharmaceuticals to Sponsor Pilot Study of..
3/14/202407:59GLOBE60 Degrees Pharmaceuticals Announces Communication from the..
2/20/202416:00EDGAR2Form 8-K - Current report
2/20/202407:59GLOBE60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies..
2/08/202407:59GLOBE60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief..
2/02/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202412:00PRNUSWallachBeth Capital Announce Closing of 60 Degrees..
1/31/202411:15GLOBE60 Degrees Pharmaceuticals Announces Closing of $2.4 Million..
1/30/202409:45PRNUSWallachBeth Capital Announces Pricing of 60 Degrees..
1/30/202409:00GLOBE60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million..
1/30/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
1/22/202417:01EDGAR2Form 8-K - Current report
1/22/202407:59GLOBE60 Degrees Pharma Plans Pivotal Babesiosis Study with..
1/16/202414:56EDGAR2Form 8-K - Current report
1/16/202407:59GLOBE60 Degrees Pharma Regains Compliance with Nasdaq Listing..
12/26/202307:59GLOBE60 Degrees Pharma Announces IRB Approval of Phase IIA Study..
11/15/202307:29GLOBE60 Degrees Pharma Announces Type C Meeting with FDA to..
10/19/202308:31GLOBE60 Degrees Pharma to Present Review of Safety, Efficacy Data..
10/12/202316:16GLOBE60 Degrees Pharmaceuticals Suspends Phase IIB Study of..
9/18/202316:16GLOBE60 Degrees Pharma Withdraws COVID Phase IIB IND, Will..
9/06/202307:31GLOBE60 Degrees Pharmaceuticals to Participate in H.C. Wainwright..
8/30/202307:32GLOBE60 Degrees Pharmaceuticals Study Results Published by New..
8/22/202307:31GLOBE60 Degrees Pharmaceuticals Receives Additional U.S. Patent..
8/15/202307:31GLOBE60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB..
7/31/202307:59GLOBE60 Degrees Pharmaceuticals Awarded Canadian Patent Covering..
7/14/202313:30PRNUSWallachBeth Capital Announce Closing Of 60 Degrees..
7/14/202312:39GLOBE60 Degrees Pharmaceuticals Announces Closing of Initial..
7/12/202313:45PRNUSWallachBeth Capital Announce Pricing Of 60 Degrees..
7/12/202312:29GLOBE60 Degrees Pharmaceuticals Announces Pricing of Initial..

Your Recent History

Delayed Upgrade Clock